33 results
6-K
EX-99.1
LSB
LakeShore Biopharma Co., Ltd
4 Sep 24
LakeShore Biopharma Announces Leadership Transitions
8:10am
has also approved the appointment of Dr. Hui Shao as the Chief Business Officer of the Company, responsible for global strategic planning and global … is also a partner at Oceanpine Capital’s healthcare practice since December 2021, where she is responsible for formulating the overall investment
6-K
EX-99.1
vq3 xjrcnaaf9hg
14 Feb 24
YS Biopharma Announces Appointment of New Directors
8:01am
POS AM
k4io946c 8x
23 Jan 24
Prospectus update (post-effective amendment)
4:18pm
6-K
4h3y588
12 Dec 23
Report of Foreign Private Issuer
6:37am
6-K
EX-99.1
0du46
14 Nov 23
Report of Foreign Private Issuer
12:00am
424B3
39pyzytitcy
26 Sep 23
Prospectus supplement
9:13am
6-K
EX-99.1
nzct 95qmt8aewzud2f
26 Sep 23
YS Biopharma Announces First Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine
9:10am
424B3
puclym 984xfrweq
15 Aug 23
Prospectus supplement
8:00am
POS AM
k1jxgagjnt
8 Aug 23
Prospectus update (post-effective amendment)
4:06pm
20-F
52083
26 Jul 23
Annual report (foreign)
4:02pm
20-F
EX-12.1
pkawx6o5zqixejiw4
26 Jul 23
Annual report (foreign)
4:02pm
20-F
EX-12.2
bzh54o
26 Jul 23
Annual report (foreign)
4:02pm
424B3
2oju6bp hdkwvmv5f
5 Jun 23
Prospectus supplement
4:03pm
F-1/A
qd591kujm
12 May 23
Registration statement (foreign) (amended)
4:05pm
UPLOAD
ug5ya4l328598s
26 Apr 23
Letter from SEC
12:00am
F-1
674 d25isckkf897v
12 Apr 23
Registration statement (foreign)
8:49am